CONMED Corporation (CNMD)
NYSE: CNMD · IEX Real-Time Price · USD
72.64
+1.56 (2.19%)
Apr 19, 2024, 4:00 PM EDT - Market closed
CONMED Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CONMED stock have an average target of 120.43, with a low estimate of 98 and a high estimate of 141. The average target predicts an increase of 65.79% from the current stock price of 72.64.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 1, 2024.
Analyst Ratings
The average analyst rating for CONMED stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $130 → $100 | Buy | Maintains | $130 → $100 | +37.67% | Feb 1, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $135 → $115 | Buy | Maintains | $135 → $115 | +58.31% | Feb 1, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $107 → $98 | Hold | Maintains | $107 → $98 | +34.91% | Feb 1, 2024 |
| Needham | Needham | Strong Buy Maintains $119 → $129 | Strong Buy | Maintains | $119 → $129 | +77.59% | Feb 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $145 → $130 | Buy | Maintains | $145 → $130 | +78.96% | Oct 27, 2023 |
Financial Forecast
Revenue This Year
1.38B
from 1.24B
Increased by 10.63%
Revenue Next Year
1.50B
from 1.38B
Increased by 8.57%
EPS This Year
4.42
from 2.04
Increased by 116.70%
EPS Next Year
5.73
from 4.42
Increased by 29.61%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.4B | 1.6B | 1.7B | 1.9B |
| Avg | 1.4B | 1.5B | 1.6B | 1.9B |
| Low | 1.3B | 1.4B | 1.5B | 1.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 14.4% | 13.0% | 16.2% | 18.0% |
| Avg | 10.6% | 8.6% | 8.8% | 14.6% |
| Low | 5.8% | 2.6% | 1.5% | 10.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.58 | 6.09 | 7.32 | 8.56 |
| Avg | 4.42 | 5.73 | 6.81 | 8.31 |
| Low | 4.21 | 5.26 | 6.24 | 7.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 124.4% | 37.8% | 27.7% | 25.6% |
| Avg | 116.7% | 29.6% | 18.9% | 22.0% |
| Low | 106.6% | 19.0% | 8.9% | 17.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.